NOACs or Warfarin in Frail patients with atrial fibrillation

Author: Dr. Ahmed Farhan     Published: 2 months ago 0 Replies

NOACs (novel oral anticoagulants) or DOACs (direct oral anticoagulants) are considered safe alternatives to VKAs ( vitamin k antagonists) like warfarin.

However, in a recent trial conducted in Frail Elderly Individuals with atrial fibrillation, switching from VKAs to NOACs resulted in a 69% increased risk of bleeding in the NOACs group (Frail-AF Trial).

Because NOACs are relatively new drugs and data regarding its safety in elderly patients with multiple comorbid conditions, polypharmacy, and bleeding risks is not sufficient.

Login to Reply

Money Back Guarantee
We return Money in 24 Hours

Secure online payment
We possess SSL / Secure —Āertificate

12/7 customer support
Well-trained & Supportive team

PMDC Verified Doctors
Authentic & updated information

Book Online and In-clinic appointment with your doctor. Consult via Video chat and get a prescription. Ask any question in the "Forum" section and get a detailed answer. Discuss your health issues.

Connect with us

Copyright @ 2023 - All Rights Reserved Reproduction of material from any pages without permission is strictly prohibited.